Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 703-710

  Hoff, Dan ^a   Sheikh, Lubna ^b   Bhattacharya, Soumya ^b   Nayar, Suprabha ^b   Webster, Thomas J ^a  

^a Brown University   (United States)

^b NATIONAL METALLURGICAL LABORATORY   (India)

Author keywords

Blood brain barrier; Ferrofluids; Iron oxide nanoparticles; Permeability

Indexed keywords

BOVINE SERUM ALBUMIN; COLLAGEN; GLUTAMIC ACID; GRAPHENE; IRON OXIDE NANOPARTICLE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; CHEMICAL MODIFICATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; IN VITRO STUDY; LIQUID; MATHEMATICAL ANALYSIS; MEMBRANE PERMEABILITY; PARTICLE SIZE; POWDER; ZETA POTENTIAL;

BLOOD-BRAIN BARRIER; FERROFLUIDS; IRON OXIDE NANOPARTICLES; PERMEABILITY;

ANIMALS; BLOOD-BRAIN BARRIER; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DEXTRANS; ENDOTHELIAL CELLS; FERRIC COMPOUNDS; FLUORESCEIN-5-ISOTHIOCYANATE; MAGNETITE NANOPARTICLES; MAGNETS; MICE; MODELS, BIOLOGICAL; PARTICLE SIZE; POLYVINYL ALCOHOL; SERUM ALBUMIN, BOVINE; X-RAY DIFFRACTION;

EID: 84873974672     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S35614     Document Type: Article

References (15)

1. Ogawa S, Lee T, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A. 1990;87:9868-9872.
2. Pisanic TR III, Blackwell JD, Shubayev VI, Finones RR, Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials. 2007;28:2572-2581.
3. Babes L, Denizot B, Tanguy G, Le Jeune JJ, Jallet P. Synthesis of iron oxide nanoparticles used as MRI contrast agents: a parametric study. J Colloid Interface Sci. 1999;212:474-482.
4. Berry CC, Curtis ASG. Functionalisation of magnetic nanoparticles for application in biomedicine. J Phys D Appl Phys. 2003;36:198-206.
5. Iannetti GD, Wise RG. BOLD functional MRI in disease and pharmacological studies: room for improvement? Magn Reson Imaging. 2007;25:978-988.
6. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature. 2001;412:150-157.
7. Nayar S, Sinha A, Pramanick AK, inventors. A biomimetic process for the synthesis of aqueous ferrofluids for biomedical applications. Application number 0672DEL2010. March 22, 2010
8. Chandra S, Sumanta S, Panchanan P. A novel synthesis of graphene by dichromate oxidation. Materials Science and Engineering B. 2010; 167:133-136.
9. Manufacturer instructions, BD Biosciences, 2011. Franklin Lakes, NJ, USA. November 1, 2101.
10. Nayar S. Improved MRI contrast enhancer in the brain and liver through the use of ferrofluids. Presented at the MRS Annual Conference, Boston, MA, USA. December 3, 2011.
11. Bennett J, Basivireddy J, Kollar A, Biron KE, McQuaid S. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol. 2010;229:180-191.
12. Brown RC, Morris AP, O'Neil RG. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res. 2007;1130:17-30.
13. Gulati K, Sinn Aw M, Losic D. Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brain. Int J Nanomedicine. 2012;7:2069-2076.
14. Saiyed ZM, Gandhi NH, Nair MPN. Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier. Int J Nanomedicine. 2010;5:157-166.
15. Dan M, Tseng MT, Wu P, Unrine JM, Grulke EA, Yokel RA. Brain microvascular endothelial cell association and distribution of a 5 nm ceria engineered nanomaterial. Int J Nanomedicine. 2012;7:4023-4036.